Loading...
NPI 1154340792 · Chicago, IL · Hematology (Internal Medicine) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Martin Tallman is a hematology (internal medicine) physician provider located in Chicago, Illinois. This profile covers 29 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Martin Tallman |
| Address | 675 N Saint Clair St |
| City | Chicago |
| State | IL |
| ZIP | 60611 |
| Taxonomy | Hematology (Internal Medicine) Physician |
| NPI Enumerated | July 18, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $634.7K |
| Medicaid | $680 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
29 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,860 | $40 | $179.8K |
| J9271 | Injection, pembrolizumab, 1 mg | 3,200 | $40 | $118.4K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,240 | $40 | $116.6K |
| J9047 | Injection, carfilzomib, 1 mg | 1,940 | $40 | $68K |
| J0897 | Injection, denosumab, 1 mg | 2,280 | $20 | $41K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,510 | $20 | $36.1K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 850 | $20 | $20.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $110 | $17.3K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 90 | $100 | $8.8K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 70 | $70 | $4.6K |
Showing 1–10 of 29
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 29 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
29 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 105 | 110 | 11,600 | $40 | $564.2K |
| J9144 | 39 | 50 | 7,740 | $40 | $341.8K |
| J1569 | 19 | 50 | 2,730 | $40 | $143K |
| J9047 | 8 | 10 | 2,070 | $40 | $108.9K |
| J0897 | 222 | 410 | 2,520 | $20 | $90.8K |
| Q5119 | 29 | 40 | 1,970 | $20 | $50.6K |
| Q5107 | 17 | 20 | 1,350 | $20 | $36.3K |
| 96413 | 160 | 370 | 130 | $100 | $19.3K |
| 99233 | 3,177 | 5,990 | 100 | $100 | $18.7K |
| 99214 | 16,598 | 18,540 | 110 | $80 | $17.1K |
Showing 1–10 of 29
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 20 | $30 | $550 |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 20 | $10 | $120 |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 138 | 150 | 170 | $50 | $39.9K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 75 | 80 | 120 | $20 | $17.1K |
Other providers in the same ZIP code as Martin Tallman, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Ann & Robert H. Lurie Children's Hospital Of Chicago | IL | Children's Hospital | $0 | $7.1M |
| Rehabilitation Institute Of Chicago | IL | Rehabilitation Hospital | $0 | $7M |
| Integrated Rehab Consultants LLC | IL | Physical Medicine & Rehabilitation Physician | $0 | $4.3M |
| Arthur Mandelin | IL | Rheumatology Physician | $1.2M | $361.3K |
| Jaideep Sohi | IL | Nuclear Radiology Physician | $1.5M | $6.9K |
| Alice Lyon | IL | Ophthalmology Physician | $1.4M | $30K |
| Jessica Altman | IL | Hematology & Oncology Physician | $1.4M | $580 |
| Murad Alam | IL | MOHS-Micrographic Surgery Physician | $1.4M | $11.7K |
| Simon Yoo | IL | MOHS-Micrographic Surgery Physician | $1.4M | $1.4K |
| Shuo Ma | IL | Hematology & Oncology Physician | $1.3M | $22.6K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.